MedPath

Flash glucose monitoring and telehealth Rapid Access Diabetes Service (RADS) compared to finger prick blood glucose checking and face to face appointments for adults with diabetes who are undergoing discharge from an acute care hospital.

Not Applicable
Recruiting
Conditions
Diabetes
Glucose instability
Metabolic and Endocrine - Diabetes
Registration Number
ACTRN12622000328774
Lead Sponsor
Sydney Local Health District
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

1. Either type 1 or type 2 diabetes.
2. Inpatients with glucose instability in hospital defined as:
a.Glucose readings over 15.0mmol/L on at least two separate occasions, and/or
b.A glucose reading under 4.0mmol/L on at least one occasion.
3. Require insulin therapy and follow-up at the RPAH Diabetes Centre RADS clinic after discharge.
4. Over 18 years of age.
5. Willingness to provide informed consent and willingness to participate and comply with the study requirements.

Exclusion Criteria

1. Those who cannot use the Flash technology after having received training.
2. Those not able or willing to use telehealth.
3. People with severe hypoglycaemia in the last 3 months.
4. Women lactating, pregnant or of childbearing potential who are not willing to avoid becoming pregnant during the study.
5. Participants with a history of a psychological illness or other conditions which may interfere with their ability to understand the study requirements.
6. Participants requiring X-ray, Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scan, or high frequency electrical heat (diathermy) treatment during the study period.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in Time In Range of glucose levels assessed by Senior Endocrinologist.<br>Both Freestyle Libre (unblinded) and Freestyle Libre PRO (blinded) record time in range and these graphs will be the basis for between group comparison.<br>[ Baseline, 5 weeks after discharge and 7 weeks after discharge (final study visit).]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath